{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:24:04Z","timestamp":1787167444901,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001786","name":"University of Adelaide","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bcp.2023.115635","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T18:55:13Z","timestamp":1685991313000},"page":"115635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Identification and kinetics of microsomal and recombinant equine liver cytochrome P450 enzymes responsible for in vitro metabolism of omeprazole"],"prefix":"10.1016","volume":"214","author":[{"given":"Gustavo","family":"Ferlini Agne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Knych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bcp.2023.115635_b0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2746\/042516409X441929","article-title":"Risk factors associated with equine gastric ulceration syndrome (EGUS) in 201 horses in Denmark","volume":"41","author":"Luthersson","year":"2009","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.bcp.2023.115635_b0010","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2460\/javma.1999.215.08.1130","article-title":"Prevalence of gastric ulcers in show horses","volume":"215","author":"McClure","year":"1999","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"5","key":"10.1016\/j.bcp.2023.115635_b0015","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/jvim.13578","article-title":"European College of Equine Internal Medicine Consensus Statement\u2014equine gastric ulcer syndrome in adult horses","volume":"29","author":"Sykes","year":"2015","journal-title":"J. Vet. Intern. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115635_b0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tvjl.2003.09.005","article-title":"Prevalence of gastric ulcers in endurance horses\u2013a preliminary report","volume":"167","author":"Nieto","year":"2004","journal-title":"Vet. J."},{"key":"10.1016\/j.bcp.2023.115635_b0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2746\/042516406776866390","article-title":"Prevalence of gastric ulceration in Swedish Standardbreds in race training","volume":"38","author":"Jonsson","year":"2006","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.bcp.2023.115635_b0030","first-page":"55","article-title":"Horse owner understanding of equine gastric ulcer syndrome (EGUS)","volume":"76","author":"Marlin","year":"2019","journal-title":"J. Equine Vet."},{"issue":"6","key":"10.1016\/j.bcp.2023.115635_b0035","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11894-008-0098-4","article-title":"Pharmacology of proton pump inhibitors","volume":"10","author":"Shin","year":"2008","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2023.115635_b0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/evj.12951","article-title":"Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: a meta-analysis","volume":"51","author":"Mason","year":"2019","journal-title":"Equine Vet. J."},{"issue":"2","key":"10.1016\/j.bcp.2023.115635_b0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jvp.12169","article-title":"Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse","volume":"38","author":"Sykes","year":"2015","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2023.115635_b0050","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/evj.12630","article-title":"The effects of dose and diet on the pharmacodynamics of omeprazole in the horse","volume":"49","author":"Sykes","year":"2017","journal-title":"Equine Vet. J."},{"issue":"6","key":"10.1016\/j.bcp.2023.115635_b0055","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/evj.12688","article-title":"Preliminary investigations into a novel, long-acting, injectable, intramuscular formulation of omeprazole in the horse","volume":"49","author":"Sykes","year":"2017","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.bcp.2023.115635_b0060","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0090-9556(24)15171-9","article-title":"Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes","volume":"28","author":"\u00c4bel\u00f6","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.bcp.2023.115635_b0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2125.1994.tb04310.x","article-title":"Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism","volume":"37","author":"Andersson","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115635_b0070","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cpt.2552","article-title":"Association of CYP2C19 Polymorphism With Proton Pump Inhibitors Effectiveness and With Fractures in Real-Life: Retrospective Cohort Study","volume":"111","author":"Gronich","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2023.115635_b0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/jvp.12371","article-title":"Pharmacokinetics and tolerability of a new formulation of omeprazole in the horse","volume":"40","author":"Di Salvo","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2023.115635_b0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jvp.12269","article-title":"Evidence for polymorphism in the cytochrome P450 2D50 gene in horses","volume":"39","author":"Corado","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2023.115635_b0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2460\/ajvr.77.9.1029","article-title":"Dextromethorphan and debrisoquine metabolism and polymorphism of the gene for cytochrome P450 isozyme 2D50 in Thoroughbreds","volume":"77","author":"Corado","year":"2016","journal-title":"Am. J. Vet. Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115635_b0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.abb.2009.02.009","article-title":"Equine cytochrome P450 2C92: cDNA cloning, expression and initial characterization","volume":"485","author":"DiMaio Knych","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bcp.2023.115635_b0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jvp.12240","article-title":"Pharmacokinetics and bioequivalence testing of five commercial formulations of omeprazole in the horse","volume":"39","author":"Sykes","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2023.115635_b0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jvp.12345","article-title":"The effects of dose and diet on the pharmacokinetics of omeprazole in the horse","volume":"40","author":"Sykes","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2023.115635_b0105","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/jvim.15971","article-title":"Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses","volume":"35","author":"Wise","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.bcp.2023.115635_b0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bcp.2019.07.005","article-title":"Characterization of the in vitro CYP450 mediated metabolism of the polymorphic CYP2D6 probe drug codeine in horses","volume":"168","author":"Knych","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115635_b0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2052.2010.02111.x","article-title":"Comparative human\u2013horse sequence analysis of the CYP3A subfamily gene cluster","volume":"41","author":"Schmitz","year":"2010","journal-title":"Anim. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2023.115635_b0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jvp.12891","article-title":"Identification and characterization of the enzymes responsible for the metabolism of the non-steroidal anti-inflammatory drugs, flunixin meglumine and phenylbutazone, in horses","volume":"44","author":"Knych","year":"2021","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2023.115635_b0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2125.1994.tb04336.x","article-title":"Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms","volume":"38","author":"Andersson","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115635_b0130","series-title":"Enzymes: a practical introduction to structure, mechanism, and data analysis","author":"Copeland","year":"2000"},{"issue":"S1","key":"10.1016\/j.bcp.2023.115635_b0135","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1365\/s10337-004-0213-0","article-title":"Detection of anti-ulcer drugs and their metabolites in horse urine by liquid chromatography\u2013mass spectrometry","volume":"59","author":"Chung","year":"2004","journal-title":"Chromatographia"},{"key":"10.1016\/j.bcp.2023.115635_b0140","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/00498254.2020.1764131","article-title":"Prediction of pharmacokinetic clearance and potential Drug-Drug interactions for omeprazole in the horse using in vitro systems","volume":"50","author":"Shibany","year":"2020","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.bcp.2023.115635_b0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2125.1993.tb00410.x","article-title":"Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism","volume":"36","author":"Andersson","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115635_b0150","first-page":"1130","article-title":"In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse","volume":"25","author":"Chauret","year":"1997","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.bcp.2023.115635_b0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00008571-199208000-00004","article-title":"Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques","volume":"2","author":"Tassaneeyakul","year":"1992","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bcp.2023.115635_b0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0026-895X(25)13354-3","article-title":"Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone","volume":"33","author":"Schwab","year":"1988","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115635_b0165","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1177\/0091270003258170","article-title":"CYP2C19-and CYP3A4-dependent omeprazole metabolism in West Mexicans","volume":"43","author":"Gonzalez","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115635_b0170","unstructured":"Zendehdel N, Biramijamal F, Hosseinnezhad A, et al. Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis. 2010."},{"issue":"5","key":"10.1016\/j.bcp.2023.115635_b0175","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3346\/jkms.2017.32.5.729","article-title":"Effects of CYP2C19 genetic polymorphisms on PK\/PD responses of omeprazole in Korean healthy volunteers","volume":"32","author":"Park","year":"2017","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.bcp.2023.115635_b0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tiv.2019.05.011","article-title":"In silico and in vitro analysis of genetic variants of the equine CYP3A94, CYP3A95 and CYP3A97 isoenzymes","volume":"60","author":"Vimercati","year":"2019","journal-title":"Toxicol. In Vitro"},{"issue":"3","key":"10.1016\/j.bcp.2023.115635_b0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/85417","article-title":"CYP3A genetics in drug metabolism","volume":"7","author":"Eichelbaum","year":"2001","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bcp.2023.115635_b0190","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1128\/AAC.47.11.3464-3469.2003","article-title":"Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes","volume":"47","author":"Park","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2023.115635_b0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1684\/epd.2021.1261","article-title":"A review of pharmacokinetic drug interactions between antimicrobial and antiseizure medications in children","volume":"23","author":"Zaccara","year":"2021","journal-title":"Epileptic Disord."},{"issue":"3","key":"10.1016\/j.bcp.2023.115635_b0200","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1006\/bbrc.1995.2854","article-title":"Effect of different solubilizing agents on the aggregation state and catalytic activity of two purified rabbit cytochrome P450 isozymes, CYP1A2 (LM4) and CYP2B4 (LM2)","volume":"217","author":"Viner","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2023.115635_b0205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/abbi.1998.0659","article-title":"Oxidation of nonionic detergents by cytochrome P450 enzymes","volume":"353","author":"Hosea","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"issue":"14","key":"10.1016\/j.bcp.2023.115635_b0210","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1021\/bi00335a058","article-title":"Effects of detergent on substrate binding and spin state of purified liver microsomal cytochrome P-450LM2 from phenobarbital-treated rabbits","volume":"24","author":"Wagner","year":"1985","journal-title":"Biochemistry"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:20:06Z","timestamp":1762096806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223002265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":42,"alternative-id":["S0006295223002265"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115635","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and kinetics of microsomal and recombinant equine liver cytochrome P450 enzymes responsible for in vitro metabolism of omeprazole","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115635"}}